Mammoth Biosciences
Agent35Agent Readiness: 35/100. Below median. Measured by StartupHub.ai. Median 41.Trust68Data Trust: 68/100. Above median. Measured by StartupHub.ai. Median 61.Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
We may earn a commission from links on this Mammoth Biosciences profile. That does not change the facts we publish.
About
Mammoth Biosciences is developing in vivo gene editing therapeutics using novel CRISPR-Cas enzymes and protein discovery technologies to deliver permanent cures for serious diseases. Their platform also enables limitless testing possibilities through a revolutionary CRISPR-based molecular diagnostics system. The company serves patients by overcoming challenges in genetic medicine and addressing unmet needs for severe conditions.
Listed competitors
A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Also in this space
Engineering custom biological systems for various applications.
Shares Biotechnology, Synthetic Biology
Biotech company developing next-generation gene writing tools for advanced therapies.
Shares Gene Editing, Drug Discovery
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Life Sciences
A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Shares Biotechnology, Life Sciences
Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
Shares Biotechnology, Life Sciences
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- mammoth.bio
- Headquarters
- Brisbane, United States
- Founded
- 2017
- Employees
- 165
- Total funding
- $258M (Other Equity)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Post-money | Lead investors |
|---|---|---|---|---|
| 10 Jan 2022 | Other Equity | $40M | ||
| 9 Sept 2021 | Series D | $150M | $1.0B | Redmile Group |
| 30 Jan 2020 | Series B | $45M | Decheng Capital | |
| 1 Aug 2018 | Series A | $23M | Mayfield Fund |
Tech stack
Detected on mammoth.bio, last scanned 24 Oct 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- Support
- HubSpot
- CMS / Builders
- WordPress
- Email provider
- Google Workspace
- Affiliate program
- Self-hosted affiliate
Mammoth Biosciences scores 50. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Mammoth Biosciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Mammoth Biosciences is 68 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Mammoth Biosciences raised?
Mammoth Biosciences has raised a total of $258M in funding. The most recent round on record is Other Equity.
How many employees does Mammoth Biosciences have?
Mammoth Biosciences has approximately 165 people on record.
Does Mammoth Biosciences have an affiliate program?
Yes, Mammoth Biosciences has an affiliate program. The program runs on Self-hosted affiliate. Register here: www.mammoth.bio/affiliates
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Mammoth Biosciences
